Change in Medicare PMPM spending on medical benefit drugs 2021-2022
In 2021-2022, Medicare per member per month (PMPM) spending on cancer drug Keytruda increased by 12.5 percent in the United States. This statistic illustrates the change in Medicare PMPM spending on leading medical benefit drugs from 2021 to 2022.